Application 215602

Type
NDA
Sponsor
AZURITY

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FLEQSUVYBACLOFENSUSPENSION;ORAL25MG/5MLYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
52652-6001FLEQSUVYbaclofenAzurity Pharmaceuticals, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83101SUPPL 2025-08-15
71774ORIG2022-08-11
70120ORIG2022-02-08
70115ORIG2022-02-08